n(g),n(g')-dimethyl-l-arginine has been researched along with Albuminuria in 21 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-one young people with Type 1 diabetes without macrovascular disease or nephropathy and 62 healthy volunteers underwent brachial artery flow-mediated dilatation (FMD) and assay of plasma ADMA and adhesion molecules." | 5.35 | A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. ( Agarwal, SC; Böger, RH; Home, PD; Lüneburg, N; Schwedhelm, E; Sibal, L, 2009) |
| " The aim of this study is to evaluate the direct effects of losartan and/or pentoxifylline on expression of renal DDAH-1 and its relation to oxidative stress in the setting of albuminuria." | 3.79 | Effects of losartan and pentoxifylline on renal dimethylarginine dimethylaminohydrolase-1 expression in proteinuric nephropathy. ( Ahn, JS; Cho, JH; Choi, JY; Hyun, SH; Kim, CD; Kim, YL; Oh, EJ; Oh, SH; Park, SH; Ryu, HM; Yoon, SH, 2013) |
| " Patients with metabolic syndrome (MS) had lower activity of gluthatione peroxidase, higher asymmetric dimethyloarginine (ADMA) and oxidized LDL cholesterol (oxyLDL) in comparison to patients without MS." | 3.78 | Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy. ( Janas, R; Litwin, M; Niemirska, A; Płudowski, P; Skorupa, E; Sladowska-Kozłowska, J; Wawer, ZT; Wierzbicka, A, 2012) |
| "Asymmetric dimethylarginine (ADMA) is associated with pulmonary hypertension (PHT) in sickle cell disease (SCD)." | 3.76 | Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. ( Biemond, BJ; Brandjes, DP; Duits, AJ; Landburg, PP; Muskiet, FA; Schnog, JB; Teerlink, T, 2010) |
| "Asymmetric dimethylarginine (ADMA) and subclinical inflammation are associated with atherosclerosis progression, whereas microalbuminuria is an established index of hypertensive organ damage." | 3.76 | ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study. ( Andrikou, E; Dimitriadis, K; Mihas, C; Miliou, A; Papademetriou, V; Stefanadi, E; Stefanadis, C; Thomopoulos, C; Tsiachris, D; Tsioufis, C, 2010) |
| "Endothelial dysfunction, characterized by reduced bioavailability of nitric oxide and increased oxidative stress, is a hallmark characteristic in diabetes and diabetic nephropathy (DN)." | 1.56 | Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. ( Awad, AS; Cooper, TK; Gao, T; Morris, SM; Stanley, K; Wetzel, MD, 2020) |
| "Albuminuria was calculated using urinary albumin and creatinine ratio (UACR)." | 1.46 | Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury. ( Balasubramanyam, M; Jayachandran, I; Manickam, N; Mohan, V; Paramasivam, P; Subramanian, SC; Sundararajan, S; Venkatesan, B, 2017) |
| "Diabetes and its complications, such as diabetic nephropathy, dramatically increase cardiovascular risk." | 1.46 | ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy. ( Bode-Böger, SM; Brilloff, S; Heinrich, A; Hohenstein, B; Hugo, CPM; Jarzebska, N; Martens-Lobenhoffer, J; Rodionov, RN; Todorov, VT; Weiss, N, 2017) |
| "Seventy patients with type 2 diabetes mellitus and 11 healthy subjects were assessed concerning urine albumin: creatinine ratio, plasma and urinary advanced glycation end-products, plasma asymmetric dimethyl-arginine, serum cystatin C, intima-media thickness in the common carotid arteries, the pulsatility index, the resistance index in the internal carotid arteries and the middle cerebral arteries, the cerebrovascular reactivity through the breath-holding test." | 1.42 | Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study. ( Bob, F; Dumitrascu, V; Gadalean, F; Gluhovschi, C; Gluhovschi, G; Jianu, DC; Petrica, L; Petrica, M; Popescu, R; Ursoniu, S; Velciov, S; Vlad, A; Vlad, D, 2015) |
| "Patients with type 2 diabetes mellitus were divided into three groups according to daily albumin excretion: normoalbuminuria, microalbuminuria and macroalbuminuria (n=30 in each)." | 1.42 | The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes. ( Aycan-Ustyol, E; Bekpinar, S; Dinccag, N; Gurdol, F; Unlucerci, Y; Yenidunya, G, 2015) |
| "Sixty-one young people with Type 1 diabetes without macrovascular disease or nephropathy and 62 healthy volunteers underwent brachial artery flow-mediated dilatation (FMD) and assay of plasma ADMA and adhesion molecules." | 1.35 | A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. ( Agarwal, SC; Böger, RH; Home, PD; Lüneburg, N; Schwedhelm, E; Sibal, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Wołyniec, W | 1 |
| Kasprowicz, K | 1 |
| Giebułtowicz, J | 1 |
| Korytowska, N | 1 |
| Zorena, K | 1 |
| Bartoszewicz, M | 1 |
| Rita-Tkachenko, P | 1 |
| Renke, M | 1 |
| Ratkowski, W | 1 |
| Wetzel, MD | 1 |
| Gao, T | 1 |
| Stanley, K | 1 |
| Cooper, TK | 1 |
| Morris, SM | 1 |
| Awad, AS | 1 |
| Jayachandran, I | 1 |
| Sundararajan, S | 1 |
| Paramasivam, P | 1 |
| Venkatesan, B | 1 |
| Subramanian, SC | 1 |
| Balasubramanyam, M | 1 |
| Mohan, V | 1 |
| Manickam, N | 1 |
| Haymann, JP | 1 |
| Hammoudi, N | 1 |
| Stankovic Stojanovic, K | 1 |
| Galacteros, F | 1 |
| Habibi, A | 1 |
| Avellino, V | 1 |
| Bartolucci, P | 1 |
| Benzerara, Y | 1 |
| Arlet, JB | 1 |
| Djebbar, M | 1 |
| Letavernier, E | 1 |
| Grateau, G | 1 |
| Tabibzadeh, N | 1 |
| Girshovich, A | 1 |
| Chaignon, M | 1 |
| Girot, R | 1 |
| Levy, P | 1 |
| Lionnet, F | 1 |
| Rodionov, RN | 1 |
| Heinrich, A | 1 |
| Brilloff, S | 1 |
| Jarzebska, N | 1 |
| Martens-Lobenhoffer, J | 1 |
| Bode-Böger, SM | 1 |
| Todorov, VT | 1 |
| Hugo, CPM | 1 |
| Weiss, N | 1 |
| Hohenstein, B | 1 |
| Triches, CB | 1 |
| Quinto, M | 1 |
| Mayer, S | 1 |
| Batista, M | 1 |
| Zanella, MT | 1 |
| Park, SH | 1 |
| Hyun, SH | 1 |
| Ryu, HM | 1 |
| Ahn, JS | 1 |
| Oh, SH | 1 |
| Oh, EJ | 1 |
| Yoon, SH | 1 |
| Choi, JY | 1 |
| Cho, JH | 1 |
| Kim, CD | 1 |
| Kim, YL | 1 |
| Petrica, L | 1 |
| Vlad, A | 1 |
| Gluhovschi, G | 1 |
| Gadalean, F | 1 |
| Dumitrascu, V | 1 |
| Vlad, D | 1 |
| Popescu, R | 1 |
| Velciov, S | 1 |
| Gluhovschi, C | 1 |
| Bob, F | 1 |
| Ursoniu, S | 1 |
| Petrica, M | 1 |
| Jianu, DC | 1 |
| Chen, J | 1 |
| Hamm, LL | 1 |
| Mohler, ER | 1 |
| Hudaihed, A | 1 |
| Arora, R | 1 |
| Chen, CS | 1 |
| Liu, Y | 1 |
| Browne, G | 1 |
| Mills, KT | 1 |
| Kleinpeter, MA | 1 |
| Simon, EE | 1 |
| Rifai, N | 1 |
| Klag, MJ | 1 |
| He, J | 1 |
| Bekpinar, S | 1 |
| Yenidunya, G | 1 |
| Gurdol, F | 1 |
| Unlucerci, Y | 1 |
| Aycan-Ustyol, E | 1 |
| Dinccag, N | 1 |
| Hanai, K | 1 |
| Babazono, T | 1 |
| Nyumura, I | 1 |
| Toya, K | 1 |
| Tanaka, N | 1 |
| Tanaka, M | 1 |
| Ishii, A | 1 |
| Iwamoto, Y | 1 |
| Guagnano, MT | 1 |
| Ferroni, P | 1 |
| Santilli, F | 1 |
| Paoletti, V | 1 |
| Manigrasso, MR | 1 |
| Pescara, L | 1 |
| Cuccurullo, C | 1 |
| Ciabattoni, G | 1 |
| Davì, G | 1 |
| Sibal, L | 1 |
| Agarwal, SC | 1 |
| Schwedhelm, E | 1 |
| Lüneburg, N | 1 |
| Böger, RH | 1 |
| Home, PD | 1 |
| Landburg, PP | 1 |
| Teerlink, T | 1 |
| Biemond, BJ | 1 |
| Brandjes, DP | 1 |
| Muskiet, FA | 1 |
| Duits, AJ | 1 |
| Schnog, JB | 1 |
| Tsioufis, C | 2 |
| Dimitriadis, K | 2 |
| Andrikou, E | 1 |
| Thomopoulos, C | 2 |
| Tsiachris, D | 1 |
| Stefanadi, E | 1 |
| Mihas, C | 1 |
| Miliou, A | 1 |
| Papademetriou, V | 2 |
| Stefanadis, C | 2 |
| Marcovecchio, ML | 1 |
| Widmer, B | 1 |
| Turner, C | 1 |
| Dunger, DB | 1 |
| Dalton, RN | 1 |
| Lu, TM | 1 |
| Chung, MY | 1 |
| Lin, CC | 1 |
| Hsu, CP | 1 |
| Lin, SJ | 1 |
| Aggelis, A | 1 |
| Kasiakogias, A | 1 |
| Tzamou, V | 1 |
| Kyvelou, SM | 1 |
| Mikhailidis, DP | 1 |
| Sladowska-Kozłowska, J | 1 |
| Litwin, M | 1 |
| Niemirska, A | 1 |
| Płudowski, P | 1 |
| Wierzbicka, A | 1 |
| Skorupa, E | 1 |
| Wawer, ZT | 1 |
| Janas, R | 1 |
| Schiffrin, EL | 1 |
| Lipman, ML | 1 |
| Mann, JF | 1 |
| Stenvinkel, P | 1 |
| Carrero, JJ | 1 |
| Axelsson, J | 1 |
| Lindholm, B | 1 |
| Heimbürger, O | 1 |
| Massy, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Dexamethasone Implant on Retinal Nerve Fiber and Optic Disc Morphology in Patients With Diabetic Maculopathy[NCT03927118] | 43 participants (Actual) | Observational | 2018-02-01 | Completed | |||
| Influence of Preoperative Hemodialysis or Intraoperative Modified Ultrafiltration on Postoperative Outcome for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery: Randomized, Controlled, Multicenter Clinical Trial[NCT00720967] | Phase 3 | 450 participants (Anticipated) | Interventional | 2008-11-30 | Not yet recruiting | ||
| Effect of Beraprost Sodium on Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy (BESTinDN Study)[NCT01796418] | 102 participants (Anticipated) | Interventional | 2013-03-31 | Recruiting | |||
| A Multicenter, Randomized Trial to Compare Xience and Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease[NCT00818792] | Phase 2 | 215 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Albuminuria
| Article | Year |
|---|---|
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarker | 2007 |
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Topics: Albuminuria; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidn | 2008 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Albuminuria
| Article | Year |
|---|---|
Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
Topics: Adult; Albuminuria; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomark | 2017 |
Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
Topics: Adult; Aged; Albuminuria; Arginine; Biomarkers; Blood Glucose; Cell Adhesion Molecules; Comorbidity; | 2015 |
17 other studies available for n(g),n(g')-dimethyl-l-arginine and Albuminuria
| Article | Year |
|---|---|
Changes in Water Soluble Uremic Toxins and Urinary Acute Kidney Injury Biomarkers After 10- and 100-km Runs.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Albuminuria; Arginine; Biomarkers; Creatinine; Fem | 2019 |
Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Topics: Adenoviridae; Albuminuria; Amidohydrolases; Animals; Arginine; Cytokines; Diabetes Mellitus, Experim | 2020 |
Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury.
Topics: Adult; Albuminuria; Animals; Arginine; Asian People; Biomarkers; Cell Line; Creatinine; Diabetes Mel | 2017 |
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
Topics: Albuminuria; Amidohydrolases; Animals; Arginine; Cell Proliferation; Creatinine; Diabetes Mellitus, | 2017 |
Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Case-Control Studies; Diabetes Complications; Diabetes Mell | 2018 |
Effects of losartan and pentoxifylline on renal dimethylarginine dimethylaminohydrolase-1 expression in proteinuric nephropathy.
Topics: Acetylglucosaminidase; Albuminuria; Amidohydrolases; Angiotensin II Type 1 Receptor Blockers; Animal | 2013 |
Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Breath Holding; Cohort Studies; Cross-Sectional Studies; Di | 2015 |
The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes.
Topics: Albuminuria; Apolipoproteins; Apolipoproteins M; Arginine; Biological Transport; Cholesterol, HDL; C | 2015 |
Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Arginine; Biomarkers; Cohort Studies; Cross-Sectional Studies; Diabetes Me | 2009 |
Determinants of platelet activation in hypertensives with microalbuminuria.
Topics: Aged; Albuminuria; Arginine; Biomarkers; Disease Progression; Endothelium; Female; Humans; Hypertens | 2009 |
A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.
Topics: Adolescent; Adult; Albuminuria; Arginine; Biomarkers; Brachial Artery; Case-Control Studies; Cell Ad | 2009 |
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
Topics: Adult; Albuminuria; Anemia, Sickle Cell; Arginine; beta-Thalassemia; Cholelithiasis; Female; Hemolys | 2010 |
ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study.
Topics: Adult; Albuminuria; Arginine; Blood Pressure; C-Reactive Protein; Creatinine; Cross-Sectional Studie | 2010 |
Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
Topics: Adolescent; Albuminuria; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Child; Diabet | 2011 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, | 2011 |
Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction.
Topics: Adult; Albuminuria; Arginine; Blood Pressure; Cross-Sectional Studies; Echocardiography; Endothelium | 2011 |
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.
Topics: Adiposity; Adolescent; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; A | 2012 |